Recurrent hyperkalaemia management and use of renin–angiotensin–aldosterone system inhibitors: a European multi-national targeted chart review

Autor: Thierry Schulmann, Luis M. Ruilope, Lars H. Lund, Patrick Rossignol, Markus Ketteler, Georgiana Cornea, Marc Pignot, David C. Wheeler, Adamasco Cupisti
Přispěvatelé: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Hospital Universitario 12 de Octubre [Madrid], University of Pisa - Università di Pisa, Department of General Internal Medicine and Nephrology, Robert-Bosch-Krankenhaus, University of Split School of Medicine, Queen Mary University of London (QMUL), Kantar Health GmbH, Real World Research & Value, Vifor Pharma Group, Karolinska Institute, Karolinska University Hospital [Stockholm], This study was developed and funded by the Vifor Pharma, Switzerland., BOZEC, Erwan
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Clinical Kidney Journal
Clinical Kidney Journal, Oxford University Press, 2020, 13 (4), pp.714-719. ⟨10.1093/ckj/sfz129⟩
Clinical Kidney Journal, 2020, 13 (4), pp.714-719. ⟨10.1093/ckj/sfz129⟩
ISSN: 2048-8505
2048-8513
DOI: 10.1093/ckj/sfz129⟩
Popis: Hyperkalaemia often occurs due to impaired excretion of potassium in patients with chronic kidney disease and other chronic conditions such as heart failure and/or diabetes mellitus.
Databáze: OpenAIRE